Test biophoton therapy for tremor
- Trial ID
- NCT06147999
- Official Title
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Goal
- Test biophoton therapy for tremor
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- First Institute of All Medicines
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
- Interventions
- Biophotonizer - a Biophoton Generator
Plain-Language Summary
Researchers want to see whether a handheld Biophotonizer light treatment can change brain function or symptoms in people with brain disorders, including Parkinson's, by promoting cellular signaling and lowering harmful inflammation. The approach uses a non-drug device that emits very low intensity biophoton light aimed at stimulating neurons and repair pathways, and it is given during an in-person hotel stay while participants keep their usual medications rather than replacing levodopa. Adults 18 and older with a clinical diagnosis of a brain disorder who can stay in a hotel and bring a caregiver to help with visits and surveys can join. People with implanted electronic devices like DBS or pacemakers, those on ventilators, with unstable medical conditions, active infections, pregnancy, or enrolled in another investigational trial are excluded.
Locations
- Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler, Pennsylvania, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Biophotonizer - a Biophoton Generator. Researchers want to see whether a handheld Biophotonizer light treatment can change brain function or symptoms in people with brain disorders, including Parkinson's, by promoting cellular signaling and lowering harmful inflammation. The approach uses a non-drug device that emits very low intensity biophoton light aimed at stimulating neurons and repair pathways, and it is given during an in-person hotel stay while participants keep their usual medications rather than replacing levodopa. Adults 18 and older with a clinical diagnosis of a brain disorder who can stay in a hotel and bring a caregiver to help with visits and surveys can join. People with implanted electronic devices like DBS or pacemakers, those on ventilators, with unstable medical conditions, active infections, pregnancy, or enrolled in another investigational trial are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 years.